Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WOOF
126
DELISTED
VCA Inc.
WOOF
| $63.7M | 0.15% |
2,032,700
+1,371,700
| +208% | +$40M |
|
127
Dollar General
DG
$26.5B
| $63.5M | 0.15% |
1,052,100
+572,400
| +119% | +$33.6M |
|
128
Commault Systems
CVLT
$5.78B
| $63.4M | 0.15% |
846,400
-60,000
| -7% | -$4.7M |
|
|
VGR
129
DELISTED
Vector Group Ltd.
VGR
| $63.2M | 0.15% |
7,291,193
-325,754
| -4% | -$2.81M |
|
130
Toyota
TM
$225B
| $63.1M | 0.15% |
517,200
+263,600
| +104% | +$33.1M |
|
|
MGLN
131
DELISTED
Magellan Health Services, Inc.
MGLN
| $62.8M | 0.15% |
1,047,499
+128,000
| +14% | +$7.64M |
|
132
HSBC
HSBC
$355B
| $62.2M | 0.15% |
1,309,550
+831,196
| +174% | +$39.4M |
|
133
Baidu
BIDU
$35.9B
| $61.9M | 0.15% |
+347,900
| New | +$56.2M |
|
134
Enterprise Products Partners
EPD
$81.8B
| $61.7M | 0.15% |
1,861,446
+547,800
| +42% | +$17.1M |
|
135
RTX Corp
RTX
$302B
| $61.4M | 0.15% |
857,742
+326,857
| +62% | +$22.3M |
|
136
Crown Castle
CCI
$31.3B
| $61.3M | 0.15% |
835,103
+706,000
| +547% | +$52.3M |
|
137
NetApp
NTAP
$38.9B
| $60.9M | 0.15% |
+1,479,532
| New | +$60.1M |
|
|
CHS
138
DELISTED
Chicos FAS, Inc.
CHS
| $60.8M | 0.15% |
3,225,000
-854,000
| -21% | -$15.1M |
|
139
Targa Resources
TRGP
$56.9B
| $59.6M | 0.14% |
675,500
-139,500
| -17% | -$11M |
|
140
Capitol Federal Financial
CFFN
$1.09B
| $59M | 0.14% |
4,875,886
+503,089
| +12% | +$6.22M |
|
141
Cogent Communications
CCOI
$554M
| $59M | 0.14% |
1,460,700
+348,600
| +31% | +$12.7M |
|
142
Equinor
EQNR
$97.2B
| $58.9M | 0.14% |
2,439,498
-2,127,800
| -47% | -$49.1M |
|
143
Liberty Media Series A
FWONA
$23.4B
| $58.9M | 0.14% |
2,264,850
+2,217,814
| +4,715% | +$58.9M |
|
|
LNKD
144
DELISTED
LinkedIn Corporation
LNKD
| $58.6M | 0.14% |
270,200
-533,700
| -66% | -$121M |
|
|
TW
145
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $58.5M | 0.14% |
458,100
+322,000
| +237% | +$37.4M |
|
146
Axos Financial
AX
$5.68B
| $58.4M | 0.14% |
2,978,000
-66,400
| -2% | -$1.19M |
|
|
ROC
147
DELISTED
ROCKWOOD HLDGS INC
ROC
| $58.1M | 0.14% |
808,400
+456,700
| +130% | +$31.1M |
|
148
HP
HPQ
$26.6B
| $58.1M | 0.14% |
4,572,013
-1,108,266
| -20% | -$12.7M |
|
|
RAI
149
DELISTED
Reynolds American Inc
RAI
| $57.9M | 0.14% |
2,317,000
-1,671,800
| -42% | -$42.2M |
|
150
Herbalife
HLF
$1.23B
| $57.9M | 0.14% |
1,471,400
+831,000
| +130% | +$28.8M |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.